Cytokinetics(CYTK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CYTK Cytokinetics

休市中 12-20 15:59:59 EST

48.87

+2.13

+4.56%

盘后48.87

+0.00+0.00%

19:46 EST

最高50.32	最低46.85	成交量380.53万
今开46.88	昨收46.74	日振幅7.42%
总市值57.67亿	流通市值57.37亿	总股本1.18亿
成交额1.86亿	换手率3.24%	流通股本1.17亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CYTK","market":"US","secType":"STK","nameCN":"Cytokinetics","latestPrice":48.87,"timestamp":1734728399999,"preClose":46.74,"halted":0,"volume":3805260,"hourTrading":{"tag":"盘后","latestPrice":48.8695,"preClose":48.87,"latestTime":"19:46 EST","volume":598850,"amount":29266068.3615,"timestamp":1734741978856},"delay":0,"floatShares":117387324,"shares":118014240,"eps":-5.375705,"marketStatus":"休市中","marketStatusCode":7,"change":2.13,"latestTime":"12-20 15:59:59 EST","open":46.88,"high":50.32,"low":46.85,"amount":185558138.4834,"amplitude":0.07424,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.375705,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1083211200000,"adjPreClose":46.74,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":46.51,"preClose":46.74,"latestTime":"09:29 EST","volume":1837,"amount":85661.95528,"timestamp":1734704999920},"postHourTrading":{"tag":"盘后","latestPrice":48.8695,"preClose":48.87,"latestTime":"19:46 EST","volume":598850,"amount":29266068.3615,"timestamp":1734741978856},"volumeRatio":2.914889904647904,"impliedVol":0.7097,"impliedVolPercentile":0.5952},"requestUrl":"/m/hq/s/CYTK","defaultTab":"news","newsList":[{"id":"2492144425","title":"Cytokinetics, Incorporated盘中异动 股价大涨5.05%报49.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492144425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492144425?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:53","pubTimestamp":1734706427,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时53分，Cytokinetics, Incorporated股票出现异动，股价急速上涨5.05%。截至发稿，该股报49.10美元/股，成交量53.878万股，换手率0.46%，振幅4.75%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体跌幅为0.39%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220225347a1fe2f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220225347a1fe2f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","CYTK","BK4588","BK4585"],"gpt_icon":0},{"id":"2488081066","title":"嗡嗡声--美国股票走势-Lululemon Athletica、邮轮股、超级微型公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2488081066","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488081066?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:47","pubTimestamp":1733154473,"startTime":"0","endTime":"0","summary":"标准普尔 500 指数  百分比涨幅前三名是：** 超级微型计算机公司  ，上涨18.6%。** Upstart Holdings Inc   : BUZZ - 在摩根大通将其评级下调至 \"减持 \"后股价下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".DJI","EQT","QLD","PERF",".IXIC","GAP","KSS","SQQQ","VYGR","SNTI","QID","FSLR","MNQmain","NCLH","LU0312595415.SGD","PSQ","TQQQ","DDM","EVEX","NQmain","DJX","TPL","FSLY",".SPX","CORZ","SDOW","DXD","PCG","LULU","DG","UDOW","AMPX","DOG","LEV","NOTE","CYTK","EVTL","NVCR","PTCT","CCL","INTC","RCL","D","NEM"],"gpt_icon":1},{"id":"2488315674","title":"BUZZ-Cytokinetics 因心脏病药物的标准审查而失败","url":"https://stock-news.laohu8.com/highlight/detail?id=2488315674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488315674?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:08","pubTimestamp":1733148525,"startTime":"0","endTime":"0","summary":"    12月2日 - ** Cytokinetics  股价盘前下跌2.3%至50.67美元 ** CYTK称美国食品和药物管理局已同意审查其心脏病药物aficamten的上市申请** 美国食品和药物管理局指定的行动日期为 2025 年 9 月 26 日 - CYTK ** 至少有两位分析师表示，由于aficamten的标准审查期与投资者对优先审查的预期不同，CYTK的股价今天可能会走弱，而优先审查可能会导致该药提前上市。** Piper Sandler称，FDA的认可增强了人们对该药成功的信心，并坚信该药的标签不会像Camzyos那么严格。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2133065610.SGD","BK4505","LU0306807586.USD","LU1323610961.USD","LU2242646821.SGD","LU1032466523.USD","LU2125154778.USD","LU1670711123.USD","LU1430594728.SGD","LU0985481810.HKD","LU1571399168.USD","IE00BSNM7G36.USD","LU1868836914.USD","LU1868836757.USD","BK4581","LU1093756325.SGD","LU1868836591.USD","BK4588","CYTK","LU0061475181.USD","BMY","LU1670710661.SGD","BK4559","LU0096364046.USD","LU1670710588.SGD","LU1868837136.USD","LU1989771016.USD","LU1670711040.USD","LU1868837300.USD","BK4534","LU0306806265.USD","BK4532","LU2242652126.USD","LU1291159041.SGD","LU1585245621.USD","LU0321505868.SGD","LU0225284248.USD","LU0114720955.EUR","LU1093756168.USD","LU2125154935.USD","LU0321505439.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4585","IE00BFTCPJ56.SGD","LU1074936037.SGD","IE0002141913.USD","LU0882574055.USD","BK4007"],"gpt_icon":0},{"id":"2484193469","title":"今日优惠-合并与收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2484193469","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484193469?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:38","pubTimestamp":1732012712,"startTime":"0","endTime":"0","summary":"    路透11月19日 - 截至格林尼治标准时间周二10:30，报导了以下竞标、兼并、收购和处置情况： ** 一份监管文件显示，美国激进投资者埃利奥特管理公司已持有东京燃气  5.03%的股份，该公司试图推动日本最大的城市燃气供应商提高股东价值。** 拜耳  与美国生物技术公司Cytokinetics  达成合作协议，获得一种试验性心脏药物在日本的某些权利，德国拜耳集团正通过小型交易加强其心血管业务。","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7504","BKKT","BK4532","BK7095","LU0612318385.USD","BK4505","LU0075056555.USD","LU0300736062.USD","LU0266512127.USD","SYA.AU","BK4168","BECN","BK4588","LU0788108826.HKD","LU1223082519.USD","LU0788109121.HKD","LU2498475776.HKD","LU1223083913.SGD","NEM","BK4585","LU0498741890.SGD","LU1023059493.AUD","BK4570","LU1430597077.USD","LU0496367417.USD","LU0055631609.USD","LU0278409577.USD","LU1303367103.USD","QXO","LU0724618789.USD","BK4112","BK4139","LU0456854461.SGD","LU0498741114.HKD","LU0330918003.SGD","CYTK","LU1223082196.USD","LU1883866441.USD","SG9999001143.SGD","BK4126","BK4104","BK4097","BERY","BK4595","BK4017","LU0300736492.USD","PLL","LU2462611646.USD","LU0612318971.USD","LU1169590202.USD"],"gpt_icon":1},{"id":"2484994779","title":"拜耳与Cytokinetics(CYTK.US)达成合作 在日本开发及商业化肥厚性心肌病疗法Aficamten","url":"https://stock-news.laohu8.com/highlight/detail?id=2484994779","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484994779?lang=zh_cn&edition=full","pubTime":"2024-11-19 16:54","pubTimestamp":1732006468,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德国拜耳公司周二与美国生物技术公司Cytokinetics达成了一项合作协议，以获得在日本独家开发和商业化Cytokinetics旗下肥厚性心肌病疗法Aficamten的权利，但须遵守Cytokinetics保留的某些开发权。拜耳在一份声明中表示，Cytokinetics将获得5000万欧元的预付款，另外还有9000万欧元的奖金——取决于某些开发成果。Cytokinetics还将从拜耳获得最高达4.9亿欧元，具体金额取决于某些销售里程碑。因此，拜耳正通过规模较小的交易以加强其心血管业务，与Cytokinetics的合作正是其中一部分。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212840.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CYTK","BK4585","BK4505","BK4139","BK4588"],"gpt_icon":0},{"id":"2484999498","title":"拜耳获得 Cytokinetics 心脏药物在日本的销售权","url":"https://stock-news.laohu8.com/highlight/detail?id=2484999498","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484999498?lang=zh_cn&edition=full","pubTime":"2024-11-19 16:22","pubTimestamp":1732004529,"startTime":"0","endTime":"0","summary":"路透法兰克福11月19日 - 拜耳BAYGn.DE周二与美国生物技术公司CytokineticsCYTK.O达成了一项合作协议，获得一种试验性心脏药物在日本的某些权利，德国拜耳集团正通过小型交易加强其心血管业务。拜耳公司在一份声明中说，Cytokinetics 公司将获得 5000 万欧元 的预付款，此外还将根据某些开发成果获得高达 9000 万欧元的收益。根据某些销售里程碑，Cytokinetics 还将从拜耳获得高达 4.9 亿欧元的收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nL4S3MQ0N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","CYTK","BK4585","BK4505"],"gpt_icon":0},{"id":"2483306429","title":"Cytokinetics, Incorporated2024财年第三财季实现净利润-1.61亿美元，同比减少24.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306429?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686423,"startTime":"0","endTime":"0","summary":"11月16日，Cytokinetics, Incorporated公布财报，公告显示公司2024财年第三财季净利润为-1.61亿美元，同比减少24.81%；其中营业收入为463000.00美元，同比增加22.49%，每股基本收益为-1.36美元。从资产负债表来看，Cytokinetics, Incorporated总负债14.50亿美元，其中短期债务30.38百万美元，资产负债比为1.00，流动比率为9.27。机构评级：截至2024年11月16日，当前有17家机构对Cytokinetics, Incorporated目标价做出预测，其中目标均价为81.29美元，其中最低目标价为60.00美元，最高目标价为120.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000111abc513e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000111abc513e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYTK"],"gpt_icon":0},{"id":"2483649305","title":"Cytokinetics, Incorporated盘中异动 急速下跌5.08%报51.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483649305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483649305?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:45","pubTimestamp":1731685505,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时45分，Cytokinetics, Incorporated股票出现波动，股价大幅跳水5.08%。截至发稿，该股报51.92美元/股，成交量30.4406万股，换手率0.26%，振幅5.80%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体跌幅为3.26%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523450698e42fe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523450698e42fe2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BK4585","BK4588","CYTK"],"gpt_icon":0},{"id":"2482482679","title":"Cytokinetics, Incorporated盘中异动 急速拉升5.00%报58.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482482679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482482679?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:53","pubTimestamp":1731084785,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日00时53分，Cytokinetics, Incorporated股票出现波动，股价快速上涨5.00%。截至发稿，该股报58.63美元/股，成交量39.0273万股，换手率0.33%，振幅4.48%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体涨幅为0.96%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109005305abae907c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109005305abae907c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","CYTK","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2481939247","title":"Cytokinetics, Incorporated盘中异动 急速上涨5.03%报55.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481939247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481939247?lang=zh_cn&edition=full","pubTime":"2024-11-07 01:35","pubTimestamp":1730914538,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日01时35分，Cytokinetics, Incorporated股票出现异动，股价大幅拉升5.03%。截至发稿，该股报55.16美元/股，成交量78.1211万股，换手率0.66%，振幅3.26%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体跌幅为0.45%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107013538a21d8a78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107013538a21d8a78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYTK","BK4585","BK4139","BK4588","BK4505"],"gpt_icon":0},{"id":"2472647698","title":"Cytokinetics, Incorporated盘中异动 快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472647698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472647698?lang=zh_cn&edition=full","pubTime":"2024-10-04 02:38","pubTimestamp":1727980712,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日02时38分，Cytokinetics, Incorporated股票出现波动，股价急速上涨5.02%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体跌幅为1.49%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004023832ab679ecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004023832ab679ecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","CYTK","BK4505","BK4588","BK4139"],"gpt_icon":0},{"id":"2460838736","title":"Cytokinetics, Incorporated2024财年第二财季实现净利润-1.43亿美元，同比减少10.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460838736","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460838736?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910672,"startTime":"0","endTime":"0","summary":"8月18日，Cytokinetics, Incorporated公布财报，公告显示公司2024财年第二财季净利润为-1.43亿美元，同比减少10.85%；其中营业收入为249000.00美元，同比减少71.28%，每股基本收益为-1.31美元。从资产负债表来看，Cytokinetics, Incorporated总负债14.15亿美元，其中短期债务30.03百万美元，资产负债比为1.08，流动比率为10.37。机构评级：截至2024年8月18日，当前有16家机构对Cytokinetics, Incorporated目标价做出预测，其中目标均价为81.75美元，其中最低目标价为60.00美元，最高目标价为107.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800071195a1684d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800071195a1684d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYTK"],"gpt_icon":0},{"id":"2458169514","title":"美国研究综述-Duolingo、Nova、全民健康服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2458169514","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458169514?lang=zh_cn&edition=full","pubTime":"2024-08-10 01:39","pubTimestamp":1723225194,"startTime":"0","endTime":"0","summary":"    路透8月9日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Duolingo、Nova 和 Universal Health Services。要点 * Duolingo Inc   ：高盛将其评级从 \"卖出 \"上调至 \"中性\"。* An2 Therapeutics Inc   ：Leerink Partners将目标价从5美元下调至1美元 * An2 Therapeutics Inc   ：Leerink Partners 将目标价从 \"跑赢大盘 \"下调至 \"跑输大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRLT","CHH","ACAD","CNC","LU2249611893.SGD","RCEL","CUBI","AMPL","DXC","BRDG","CARG","LU0823414551.USD","BK4116","DOCS","WMS","ARHS","CTRE","ARRY","DOCN","AKAM","BMBL","EGHT","LU2362541513.USD","BK4535","ARI","BK4178","BK4554","EB","CRNC","LU2413666004.HKD","LU0757428866.USD","AVAH","ASPN","ASAN","BE","LU1093756325.SGD","DNTH","LU2362541273.HKD","CYTK","IE00B19Z4B17.USD","DDOG","IRON","CABA","AXGN","ARWR","DUOL","BLDR","LU1543694498.USD","LAW","SKIN"],"gpt_icon":0},{"id":"1158625581","title":"异动解读 | 生物科技股CYTK盘中大涨6%,分析师看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1158625581","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158625581?lang=zh_cn&edition=full","pubTime":"2024-08-09 16:11","pubTimestamp":1723191064,"startTime":"0","endTime":"0","summary":"生物科技公司Cytokinetics今日盘中股价大涨6.23%,引发市场关注。分析师预计,随着公司在研药物管线的推进,CYTK在2026年和2027年将实现正EPS和营收的大幅增长。数据显示,CYTK所在的生物技术行业今日整体上涨3.08%。总的来说,尽管没有直接新闻解释CYTK股价上涨的原因,但分析师对公司长期前景的乐观预期,以及生物科技行业的良好表现,或是推动股价上涨的主要驱动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYTK"],"gpt_icon":0},{"id":"2458474103","title":"Cytokinetics, Incorporated盘中异动 下午盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458474103","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458474103?lang=zh_cn&edition=full","pubTime":"2024-08-09 01:37","pubTimestamp":1723138620,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日01时37分，Cytokinetics, Incorporated股票出现波动，股价急速上涨5.00%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体涨幅为3.08%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Senti Biosciences, Inc.、Aldeyra Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为423.13%、296.31%、198.97%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为130.30%、54.41%、45.58%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809013701941ff82f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809013701941ff82f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","CYTK","BK4505","BK4585"],"gpt_icon":0},{"id":"2457834782","title":"Cytokinetics Inc   预计每股亏损1.06美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457834782","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457834782?lang=zh_cn&edition=full","pubTime":"2024-08-07 10:06","pubTimestamp":1722996383,"startTime":"0","endTime":"0","summary":"   * Cytokinetics公司   将于8月8日公布截至2024年6月30日的财报，预计该公司的季度收入将有所增长。* LSEG 分析师对 Cytokinetics Inc 的平均预期为每股亏损 1.06 美元。* 华尔街对 Cytokinetics Inc 的 12 个月目标价中位数为 85.00 美元，高于其上次收盘价 53.54 美元。8月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Cytokinetics Inc   预计每股亏损1.06美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYTK"],"gpt_icon":0},{"id":"2457577832","title":"Cytokinetics, Incorporated盘中异动 大幅下挫6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457577832","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457577832?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:38","pubTimestamp":1722865100,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时38分，Cytokinetics, Incorporated股票出现波动，股价急速下跌6.07%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体跌幅为1.94%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052138209f10731d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052138209f10731d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","CYTK","BK4588","BK4505"],"gpt_icon":0},{"id":"2445780640","title":"美国研究综述-CarMax、礼来公司、微策略公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2445780640","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445780640?lang=zh_cn&edition=full","pubTime":"2024-06-24 19:57","pubTimestamp":1719230267,"startTime":"0","endTime":"0","summary":"    路透6月24日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 CarMax、礼来和 MicroStrategy。股票条目按字母顺序排列。* Agilysys Inc   ：威廉-布莱尔给予该公司 \"跑赢大盘 \"的评级。* Ally Financial Inc   ：花旗集团给予该公司买入评级，目标价50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPAY","LU1623119135.USD","ALLY","T","DAY","AVB","LU0820561909.HKD","BK4108","LU1712237335.SGD","BOKF","FITB","AGYS","DMRC","CADE","FHN","BKU","EWBC","NVDA","DLR","CARR","ASB","COLB","CFR","LNG","CPT","FHB","ARGX","NVRI","RCUS","FDX","LU0011850046.USD","KMX","CMA","EQR","AEE","AAPL","LLY","BIO","MSTR","COCH","CNK","CYTK","LU0097036916.USD","FDS","BK4227","ESS","BK4532","BK4082","CYRX","IE0009355771.USD","GTLS","EA"],"gpt_icon":0},{"id":"2445049041","title":"美国研究综述-卡马斯、礼来、微策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2445049041","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445049041?lang=zh_cn&edition=full","pubTime":"2024-06-24 15:45","pubTimestamp":1719215146,"startTime":"0","endTime":"0","summary":"要闻             * Carmax Inc   ：加拿大皇家银行将其目标价从 73 美元上调至 75 美元             * 礼来   ：杰富瑞将目标价从994美元上调至1015美元             * 微策略公司  ：Canaccord Genuity将目标价从2047美元下调至1826美元             * Sharecare Inc   ：Canaccord Genuity将目标价从买入下调至持有             * 赛默飞世尔科技公司   ：加拿大皇家银行将目标价从662美元下调至660美元 以下是路透周一报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","BK4578","LU1989771016.USD","T","BK4589","LU0251142724.SGD","IE00BJT1NW94.SGD","LU1551013342.USD","CYTK","CYRX","LU0266512127.USD","TMO","MPC","SITC","LLY","IE00B3S45H60.SGD","LU0289739699.SGD","WAL","WKHS","VLO","TMUS","BK4585","PYCR","RGEN","PCTY","QDEL","KMX","MSTR","BIO","NVDA","VZ","DAY","DLR","IE00B1BXHZ80.USD","PSX","BK4579","SRPT","SHCR","IFF","LNG","LU0321505439.SGD","COCH","KBH","LU1267930573.SGD","BK4581","FDS","PAYC","BK4588","BK4587"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cytokinetics.com","stockEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0199},{"period":"3month","weight":-0.0911},{"period":"6month","weight":-0.0869},{"period":"1year","weight":0.0904},{"period":"ytd","weight":-0.4147}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cytokinetics, Incorporated于1997年8月5日成立，符合特拉华州的法律规定。它是一家处于临床阶段的生物制药公司，主要致力于为重大疾病和糟糕的医疗条件提供潜在的治疗方法的这样一种调节肌肉功能的新型小分子治疗方法的发现和发展。它目前处于发展阶段，着重于科研，开发药品筛选技术和融资。","yearOnYearQuotes":[{"month":1,"riseRate":0.45,"avgChangeRate":0.000078},{"month":2,"riseRate":0.5,"avgChangeRate":-0.02195},{"month":3,"riseRate":0.5,"avgChangeRate":0.003043},{"month":4,"riseRate":0.6,"avgChangeRate":0.014141},{"month":5,"riseRate":0.619048,"avgChangeRate":0.033871},{"month":6,"riseRate":0.380952,"avgChangeRate":-0.003192},{"month":7,"riseRate":0.666667,"avgChangeRate":0.056602},{"month":8,"riseRate":0.666667,"avgChangeRate":0.045334},{"month":9,"riseRate":0.380952,"avgChangeRate":0.009349},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.081654},{"month":11,"riseRate":0.47619,"avgChangeRate":0.018926},{"month":12,"riseRate":0.47619,"avgChangeRate":0.105806}],"exchange":"NASDAQ","name":"Cytokinetics","nameEN":"Cytokinetics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cytokinetics(CYTK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cytokinetics(CYTK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cytokinetics,CYTK,Cytokinetics股票,Cytokinetics股票老虎,Cytokinetics股票老虎国际,Cytokinetics行情,Cytokinetics股票行情,Cytokinetics股价,Cytokinetics股市,Cytokinetics股票价格,Cytokinetics股票交易,Cytokinetics股票购买,Cytokinetics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cytokinetics(CYTK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cytokinetics(CYTK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}